SEARCH

SEARCH BY CITATION

Disclosure

  1. Disclosure
  2. References

Gregory Krauss, MD has received research support from UCB S.A., Johnson & Johnson Inc., SK-Biosciences Corporation, Eisai Inc., Sepracor Inc., and Icagen, Inc., and has served as a paid consultant for Eisai Inc. and UCB S.A. Elinor Ben-Menachem, MD, PhD, has taken honorarium for speaking for UCB S.A., Janssen-Cilag EMEA, Bial, Eisai Inc., and Valeant, and has received support from Cyberonics, Inc., Bial, Eisai Inc., Pfizer Inc., Johnson & Johnson Inc., and UCB S.A. She has also served as a paid consultant for UCB S.A., Eisai Inc., Bial, Valeant, and Sanofi-Aventis. Melissa Brock, PharmD, John G. Whitesides, PhD, and Martin E. Johnson, MS are employees of SCHWARZ BIOSCIENCES, a member of the UCB group. The remaining authors have no conflicts of interest to disclose.

References

  1. Disclosure
  2. References